2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
2
Pain
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Uterine Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Mouth Neoplasms
1
Lung Neoplasms
1
Leiomyoma
1
Inflammation
1
Hyperuricemia
1
Gout
1
Dysmenorrhea
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Arthritis
1
Interventions
ulipristal acetate
20
Uterine Myomectomy
19
telapristone acetate
18
vilaprisan
12
relugolix
12
Leuprolide
11
Uterine Artery Embolization
10
estradiol, norethindrone drug combination
9
asoprisnil
9
Estradiol
8
elagolix
7
Tranexamic Acid
7
Mifepristone
7
Bupivacaine
7
ulipristal
6
Norethindrone Acetate
6
Hysterectomy
6
Saline Solution
5
linzagolix
4
epigallocatechin gallate
4
Sodium Chloride
4
Misoprostol
4
Letrozole
4
Vitamin B 6
3
Tablets
3
Surveys and Questionnaires
3
Sugars
3
Radiofrequency Ablation
3
Lidocaine
3
Hysteroscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leiomyoma
×
Naproxen
×
Clear all
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled